pre-miRNA Information
pre-miRNA hsa-mir-124-1   
Genomic Coordinates chr8: 9903388 - 9903472
Description Homo sapiens miR-124-1 stem-loop
Comment miR-124 was first identified by cloning studies in mouse . The 5' end of the miRNA may be offset with respect to previous annotations.
RNA Secondary Structure
Associated Diseases
pre-miRNA hsa-mir-124-2   
Genomic Coordinates chr8: 64379149 - 64379257
Description Homo sapiens miR-124-2 stem-loop
Comment miR-124 was first identified by cloning studies in mouse . The 5' end of the miRNA may be offset with respect to previous annotations.
RNA Secondary Structure
Associated Diseases
pre-miRNA hsa-mir-124-3   
Genomic Coordinates chr20: 63178500 - 63178586
Description Homo sapiens miR-124-3 stem-loop
Comment miR-124 was first identified by cloning studies in mouse . The 5' end of the miRNA may be offset with respect to previous annotations.
RNA Secondary Structure
Associated Diseases

Mature miRNA Information
Mature miRNA hsa-miR-124-5p
Sequence 14| CGUGUUCACAGCGGACCUUGAU |35
Evidence Experimental
Experiments Cloned
Editing Events in miRNAs
Modification Type Position on miR Chromosome DNA Strand Genomic Position (hg38) List of PMIDs Variant details
A-to-I 8 8 + 64379180 29233923 MiREDiBase
SNPs in miRNA
Mutant ID Mutant Position Mutant Source
rs1280076135 1 dbSNP
rs775858016 4 dbSNP
rs760972715 7 dbSNP
rs1334649236 11 dbSNP
rs1160219511 12 dbSNP
rs764591061 12 dbSNP
rs1261326747 13 dbSNP
rs1344491363 20 dbSNP
rs1340798465 20 dbSNP
Putative Targets

miRNA Expression profile
Human miRNA Tissue Atlas
miRNAs in Extracellular Vesicles
Circulating MicroRNA Expression Profiling
Biomarker Information
Biomarker ID Name Type Discovered From Mode Level Source Testing Methods
B28CWB miR-124 Safety Biomarker (SAF); Monitoring Biomarker (MOI) Clinical/Experimental Data Expression Increase Plasma Polymerase chain reaction
B28CWB miR-124 Safety Biomarker (SAF); Monitoring Biomarker (MOI) Clinical/Experimental Data Expression Decrease Neuron Reverse transcription-polymerase chain reaction
B28CWB miR-124 Safety Biomarker (SAF); Monitoring Biomarker (MOI) Clinical/Experimental Data Expression Decrease Peripheral blood mononuclear cell Reverse transcription-polymerase chain reaction
Gene Information
Gene Symbol FXR2   
Synonyms FMR1L2, FXR2P
Description FMR1 autosomal homolog 2
Transcript NM_004860   
Expression
Putative miRNA Targets on FXR2
3'UTR of FXR2
(miRNA target sites are highlighted)
>FXR2|NM_004860|3'UTR
   1 AACCTCCAACCTGCACCCCTCCCTTCTCCATCTCGCTTGCTGCCCAACACCATGGCCCTCACAGGCCCAACTGACCTGCG
  81 CTGGAGCTGCTCTTATCTAGGGGGGAGGGGGGTGGCACAGCAGCTTGGGTACCCCCCAACCTCCAGGAGCTAGTGGAGGG
 161 GTGTGTAACAGGGTCATACCCCCTCCCTCTTGTCCACCCTACCCCCAGGGTAAGGGGAGCCTCTCTCCTTCCCCATCAGA
 241 CTGGATGTGCCTTTATCCTCTAATGCCCCAATCTCTCTCTGAACACCCCCATTCTCCACCTGTTGGTGGGGGGTGCTCCT
 321 CGACCCACCCAGATTTGACCGTTCAGGGGGCCTCCCCTGCTATCCCTCCTCCCATCCTGTACCCCCCATTTCTGGGGCCT
 401 CATCACTGTGGAAGACGGGGATAGTAAGAGATAAGTGGGTGGGAGGCACGGGGAAGGTTTTGGAGTAGAACCAGGGGTGT
 481 GTATGAAGGGGGGTGACAAGGTCCCCCTGGGGAGGGGACCAACCTTGTCTGGTGGATGAGAAGGCGTATTTATTTTTCAC
 561 TGTACAGTATTTAAAAAGAGAATAAAAAAATCCAAATGGCAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
Target sites Provided by authors   Predicted by miRanda    DRVs    SNPs    DRVs & SNPs
miRNA-target interactions
(Predicted by miRanda)
ID Duplex structure Position Score MFE
1
miRNA  3' uaGUUCCAGGCGACACUUGUGc 5'
            |||  ||: || ||||||| 
Target 5' ccCAATCTCT-CTCTGAACACc 3'
267 - 287 159.00 -10.10
2
miRNA  3' uagUUCCAGGCGACAC-UUGUgc 5'
             :|||   | |||| ||||  
Target 5' gtgGAGG---GGTGTGTAACAgg 3'
153 - 172 104.00 -11.70
3
miRNA  3' uaguuccAG-GCG-AC-AC---UUGUGc 5'
                 || ||| || ||   ||||| 
Target 5' ttctccaTCTCGCTTGCTGCCCAACACc 3'
24 - 51 103.00 -10.30
DRVs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
COSN30110024 6 COSMIC
COSN518957 18 COSMIC
COSN15618829 36 COSMIC
COSN30109209 39 COSMIC
COSN26743061 40 COSMIC
COSN24393362 59 COSMIC
COSN30523285 73 COSMIC
COSN31586278 80 COSMIC
COSN26677248 150 COSMIC
COSN31483937 181 COSMIC
COSN31606824 202 COSMIC
COSN22397869 249 COSMIC
COSN23015248 344 COSMIC
COSN193543 404 COSMIC
COSN31551629 502 COSMIC
COSN32056071 506 COSMIC
COSN193542 558 COSMIC
COSN31522915 599 COSMIC
SNPs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
rs777787552 3 dbSNP
rs1215437653 4 dbSNP
rs751897191 9 dbSNP
rs1287230681 10 dbSNP
rs1430590319 12 dbSNP
rs964637128 14 dbSNP
rs1305275629 16 dbSNP
rs780435818 18 dbSNP
rs1423130541 21 dbSNP
rs1250906907 23 dbSNP
rs200224563 24 dbSNP
rs550664652 25 dbSNP
rs1162527008 26 dbSNP
rs750555216 29 dbSNP
rs1420991875 35 dbSNP
rs765500745 44 dbSNP
rs1422754014 48 dbSNP
rs374532252 50 dbSNP
rs1441376005 51 dbSNP
rs1369845858 52 dbSNP
rs887643255 58 dbSNP
rs1306548430 62 dbSNP
rs1254746132 65 dbSNP
rs1026294308 79 dbSNP
rs972089999 80 dbSNP
rs963264566 87 dbSNP
rs1395556386 88 dbSNP
rs1313623874 90 dbSNP
rs1206613804 96 dbSNP
rs1016209850 101 dbSNP
rs1273641399 105 dbSNP
rs1342673840 106 dbSNP
rs1207159146 109 dbSNP
rs187608139 111 dbSNP
rs1181952922 113 dbSNP
rs1056478916 118 dbSNP
rs1447279347 128 dbSNP
rs1273737432 129 dbSNP
rs778572420 130 dbSNP
rs953201437 133 dbSNP
rs756682446 153 dbSNP
rs528984923 154 dbSNP
rs1173113196 155 dbSNP
rs926882751 159 dbSNP
rs997272661 161 dbSNP
rs1465555897 164 dbSNP
rs902955245 173 dbSNP
rs1043841793 181 dbSNP
rs1358199772 183 dbSNP
rs1297176938 185 dbSNP
rs1433126386 185 dbSNP
rs1041353838 186 dbSNP
rs78125130 187 dbSNP
rs914112706 189 dbSNP
rs988948747 191 dbSNP
rs539846771 192 dbSNP
rs955845015 198 dbSNP
rs1210818532 199 dbSNP
rs1257212623 202 dbSNP
rs894020953 203 dbSNP
rs922901515 207 dbSNP
rs1248290969 209 dbSNP
rs1450404691 228 dbSNP
rs1309971454 232 dbSNP
rs1423577417 233 dbSNP
rs1414392290 234 dbSNP
rs1410441064 235 dbSNP
rs1408332575 241 dbSNP
rs1455743571 260 dbSNP
rs975792361 264 dbSNP
rs1389680197 267 dbSNP
rs1053971570 271 dbSNP
rs1272855749 273 dbSNP
rs938299081 281 dbSNP
rs1219716194 295 dbSNP
rs1303345856 296 dbSNP
rs926806706 304 dbSNP
rs1326414214 305 dbSNP
rs1006180153 308 dbSNP
rs951840609 309 dbSNP
rs1407501773 310 dbSNP
rs1047022175 312 dbSNP
rs949485849 313 dbSNP
rs1477931974 318 dbSNP
rs919350834 321 dbSNP
rs1432093218 322 dbSNP
rs1471620186 322 dbSNP
rs993959212 335 dbSNP
rs1415153550 340 dbSNP
rs532565520 341 dbSNP
rs972037438 341 dbSNP
rs963377425 344 dbSNP
rs896585215 345 dbSNP
rs1436968259 352 dbSNP
rs909095164 357 dbSNP
rs1348569845 373 dbSNP
rs1004007403 374 dbSNP
rs1048119 392 dbSNP
rs774207388 416 dbSNP
rs528030864 417 dbSNP
rs1226233468 418 dbSNP
rs1288745342 427 dbSNP
rs1048131 428 dbSNP
rs1002170983 439 dbSNP
rs953460029 442 dbSNP
rs905237486 445 dbSNP
rs1030147190 449 dbSNP
rs997771497 450 dbSNP
rs867123244 453 dbSNP
rs1182142667 454 dbSNP
rs946994304 454 dbSNP
rs892623431 458 dbSNP
rs1471213536 460 dbSNP
rs1161637297 463 dbSNP
rs967128982 476 dbSNP
rs1413351554 479 dbSNP
rs748993481 481 dbSNP
rs1011163188 483 dbSNP
rs560584630 489 dbSNP
rs1290362841 491 dbSNP
rs1227491735 493 dbSNP
rs1409099095 494 dbSNP
rs892794922 494 dbSNP
rs1308608109 503 dbSNP
rs1336962780 504 dbSNP
rs1332969254 508 dbSNP
rs1290386923 521 dbSNP
rs777340236 522 dbSNP
rs1283182735 527 dbSNP
rs1356602397 536 dbSNP
rs545587425 545 dbSNP
rs976270495 546 dbSNP
rs866743018 560 dbSNP
rs1340545006 573 dbSNP
rs577788423 580 dbSNP
rs756240046 582 dbSNP
rs183985449 584 dbSNP
rs755759540 589 dbSNP
rs943012259 591 dbSNP
rs1185525562 592 dbSNP
rs1046532361 593 dbSNP
rs113595529 601 dbSNP
Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions TZM-bl
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL ...

- Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio.

miRNA-target interactions (Provided by authors)
ID Duplex structure Position
1
miRNA  3' uaGUUCCAGGCGACACUUGUGc 5'
            |||  ||: || ||||||| 
Target 5' ccCAAUCUCU-CUCUGAACACc 3'
2 - 22
Article - Whisnant AW; Bogerd HP; Flores O; Ho P; et al.
- mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
CLIP-seq Support 1 for dataset GSM1462574
Method / RBP PAR-CLIP / AGO2
Cell line / Condition TZM-bl / TZM-bl ami BaL
Location of target site ENST00000250113.7 | 3UTR | CCCCAAUCUCUCUCUGAACACCCCCAUUCUCCACCUG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 23592263 / GSE59944
CLIP-seq Viewer Link
MiRNA-Target Expression Profile
Dataset Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
GSE38974 Chronic obstructive pulmonary disease -0.55 2.2e-3 -0.522 3.7e-3 25 Click to see details
GSE32688 Pancreatic cancer 0.479 2.8e-3 0.476 2.9e-3 32 Click to see details
GSE28544 Breast cancer -0.522 4.4e-3 -0.574 1.7e-3 24 Click to see details
GSE17498 Multiple myeloma -0.284 3.8e-2 -0.208 9.9e-2 40 Click to see details
GSE21687 Ependynoma primary tumors 0.173 8.6e-2 0.044 3.6e-1 64 Click to see details
GSE19350 CNS germ cell tumors 0.247 2.2e-1 0.469 6.2e-2 12 Click to see details
GSE38226 Liver fibrosis 0.14 2.7e-1 -0.206 1.9e-1 21 Click to see details
GSE42095 Differentiated embryonic stem cells -0.105 3.2e-1 0.054 4.0e-1 23 Click to see details
GSE34608 Pulmonary tuberculosis and sarcoidosis -0.072 3.8e-1 0.412 3.6e-2 20 Click to see details
GSE26953 Aortic valvular endothelial cells -0.052 4.0e-1 -0.218 1.5e-1 24 Click to see details
GSE28260 Renal cortex and medulla -0.063 4.2e-1 -0.011 4.9e-1 13 Click to see details
GSE28260 Renal cortex and medulla -0.063 4.2e-1 -0.011 4.9e-1 13 Click to see details
MiRNA-Target Expression Profile (TCGA)
Tumor Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
-0.063 4.2e-1 -0.011 4.9e-1 13 Click to see details
-0.063 4.2e-1 -0.011 4.9e-1 13 Click to see details
-0.063 4.2e-1 -0.011 4.9e-1 13 Click to see details
65 hsa-miR-124-5p Target Genes:
Functional analysis:
ID Target Description Validation methods
Strong evidence Less strong evidence
MIRT064177 KIAA1804 mitogen-activated protein kinase kinase kinase 21 2 2
MIRT069736 FOXG1 forkhead box G1 2 4
MIRT086429 NABP1 nucleic acid binding protein 1 2 6
MIRT105334 SLC7A2 solute carrier family 7 member 2 2 4
MIRT110455 PLEKHA1 pleckstrin homology domain containing A1 2 2
MIRT172998 YTHDF3 YTH N6-methyladenosine RNA binding protein 3 2 2
MIRT196428 TAOK1 TAO kinase 1 2 14
MIRT325704 CSTF2 cleavage stimulation factor subunit 2 2 2
MIRT365670 TSC22D3 TSC22 domain family member 3 2 4
MIRT365873 XIAP X-linked inhibitor of apoptosis 2 2
MIRT404126 ASB1 ankyrin repeat and SOCS box containing 1 2 2
MIRT404626 LCOR ligand dependent nuclear receptor corepressor 2 2
MIRT405284 ARF1 ADP ribosylation factor 1 2 2
MIRT406099 PAGR1 PAXIP1 associated glutamate rich protein 1 2 2
MIRT446627 SDC3 syndecan 3 2 2
MIRT446906 RGS5 regulator of G protein signaling 5 2 2
MIRT461790 FXR2 FMR1 autosomal homolog 2 2 2
MIRT463982 WEE1 WEE1 G2 checkpoint kinase 2 4
MIRT464204 VGLL4 vestigial like family member 4 2 2
MIRT472790 MTMR4 myotubularin related protein 4 2 4
MIRT473485 MCFD2 multiple coagulation factor deficiency 2 2 2
MIRT481124 AZIN1 antizyme inhibitor 1 2 4
MIRT485060 SUCO SUN domain containing ossification factor 2 2
MIRT487343 HLA-DRA major histocompatibility complex, class II, DR alpha 2 2
MIRT491948 VPS52 VPS52, GARP complex subunit 2 2
MIRT497208 CDH7 cadherin 7 2 2
MIRT497476 TOR1AIP2 torsin 1A interacting protein 2 2 2
MIRT528203 NELFE negative elongation factor complex member E 2 2
MIRT529255 TRIM4 tripartite motif containing 4 2 4
MIRT530096 PSAPL1 prosaposin like 1 (gene/pseudogene) 2 2
MIRT530597 C7orf33 chromosome 7 open reading frame 33 2 4
MIRT534980 PSAT1 phosphoserine aminotransferase 1 2 4
MIRT538326 CSGALNACT1 chondroitin sulfate N-acetylgalactosaminyltransferase 1 2 2
MIRT561237 ZNF652 zinc finger protein 652 2 2
MIRT562035 KRAS KRAS proto-oncogene, GTPase 2 2
MIRT563120 THAP5 THAP domain containing 5 2 2
MIRT563538 RBM41 RNA binding motif protein 41 2 2
MIRT566037 REV3L REV3 like, DNA directed polymerase zeta catalytic subunit 2 2
MIRT566505 PAWR pro-apoptotic WT1 regulator 2 2
MIRT566745 MRPL35 mitochondrial ribosomal protein L35 2 2
MIRT566850 LRRC58 leucine rich repeat containing 58 2 2
MIRT568077 CELF2 CUGBP Elav-like family member 2 2 2
MIRT576826 Tgfbr3 transforming growth factor, beta receptor III 2 2
MIRT608870 NR2E1 nuclear receptor subfamily 2 group E member 1 2 4
MIRT611997 VAC14 Vac14, PIKFYVE complex component 2 2
MIRT614054 FAM89A family with sequence similarity 89 member A 2 2
MIRT618800 SPATA21 spermatogenesis associated 21 2 2
MIRT619389 RSPH3 radial spoke head 3 homolog 2 2
MIRT622282 SH3TC2 SH3 domain and tetratricopeptide repeats 2 2 2
MIRT624026 EN2 engrailed homeobox 2 2 2
MIRT626000 MPEG1 macrophage expressed 1 2 2
MIRT641792 USP32 ubiquitin specific peptidase 32 2 2
MIRT651599 WDFY2 WD repeat and FYVE domain containing 2 2 2
MIRT659662 CDC73 cell division cycle 73 2 2
MIRT663010 KIAA1586 KIAA1586 2 2
MIRT663561 ASTN2 astrotactin 2 2 2
MIRT669312 C16orf72 chromosome 16 open reading frame 72 2 2
MIRT685216 POTED POTE ankyrin domain family member D 2 2
MIRT695757 ZNF117 zinc finger protein 117 2 2
MIRT697909 TXNRD1 thioredoxin reductase 1 2 2
MIRT707181 RPH3A rabphilin 3A 2 2
MIRT707214 TRIM13 tripartite motif containing 13 2 2
MIRT707478 SLCO4C1 solute carrier organic anion transporter family member 4C1 2 2
MIRT719507 LMAN2L lectin, mannose binding 2 like 2 2
MIRT755814 PARP1 poly(ADP-ribose) polymerase 1 2 1
miRNA-Drug Associations
miRNA Small Melocule FDA CID Detection Method Condition PMID Year Expression Pattern of miRNA
miR-124 5-aminoimidazole-4-carboxamide-1-β-d-ribofuranoside (AICAR) NULL 16078949 Microarray hepatocytes 23107762 2013 up-regulated
miR-124 Hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) NULL 8490 Microarray mouse brain 19270793 2009 up-regulated
miR-124 Vorinostat (SAHA) approved 5311 Microarray A549 human non-small cell lung cancer cells 19513533 2009 up-regulated
miR-124 Cocaine NULL 446220 Quantitative real-time PCR HEK293 cells or rat brain parts 19703567 2009 down-regulated
miR-124 Arsenic trioxide approved 14888 Quantitative real-time PCR acute promyelocytic leukemia 22072212 2012 up-regulated
miR-124 Chaihu Shugan San NULL NULL Microarray hippocampus 23947143 2013 up-regualted
miR-124 Perfluorooctane sulfonate NULL 74483 Microarray zebrafish embryos 20878907 2011 up-regulated
miR-124 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) NULL 15625 Microarray embryos 22921993 2012 down-regulated
miRNA-Drug Resistance Associations
miRNA Drug Name CID NSC FDA Effect/Pattern Detection Method Level Phenotype Condition
hsa-miR-124-5p Paclitaxel 36314 NSC125973 approved resistant High Laryngeal Cancer cell line (Hep2)
hsa-miR-124-5p Cisplatin 5460033 NSC119875 approved sensitive High Gastric Cancer cell line (MGC803)
hsa-miR-124-5p Methotrexate 126941 NSC740 approved resistant cell line (HT29)
hsa-miR-124-5p Cisplatin 5460033 NSC119875 approved sensitive cell line (RPMI2650)
hsa-miR-124-5p Sunitinib 5329102 NSC750690 approved resistant tissue (CardB)
hsa-miR-124-5p Paclitaxel 36314 NSC125973 approved sensitive cell line (PC3PR20)
hsa-miR-124-5p Cisplatin 5460033 NSC119875 approved sensitive cell line (A549)
hsa-miR-124-5p Neoadjuvant chemotherapy sensitive tissue (breast cancer)
hsa-miR-124-5p Neoadjuvant chemotherapy sensitive tissue (breast cancer)
hsa-miR-124-5p Paclitaxel/Docetaxel/Vinorelbine/Doxorubicin/Etoposide resistant cell line (Bads-200)

Error report submission